Dr. Georgia M. Beasley, MD

Dr. Beasley practices at Duke University Hospital in Durham, North Carolina, part of Duke University.

Dr. Beasley's NPI, 1861659567, was assigned on May 20, 2008. Dr. Beasley graduated from Duke University School Of Medicine in 2008. Dr. Beasley holds North Carolina license 2017-00134.

Dr. Beasley's primary practice is Duke University Hospital, at 2301 Erwin Rd, Durham, NC 27705 in Durham County. The practice phone is (919) 684-8111.

Dr. Beasley's primary practice is Duke University Hospital in Durham, North Carolina, part of Duke University. The medical group on file is Duke Health Integrated Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beasley practices. Vendor and product names are available with a free account.

Surgical oncology is Dr. Beasley's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Beasley is board certified in complex general surgical oncology by the American Board of Surgery. Dmand AI has Dr. Beasley's licenses on file in 2 states: North Carolina and Ohio.

Dmand AI lists cancerous skin growth removal among the conditions Dr. Beasley treats.

CMS data shows 266 Medicare services from Dr. Beasley across 7 procedure codes in 2024, for 140 Medicare patients. Medicare paid $21,621 for them.

CMS counts 140 Medicare patients who saw Dr. Beasley in 2024. The largest group is 65 to 74, with 61 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beasley's median patient age at 75, with 29% women.

In 2016, Dr. Beasley wrote 13 Medicare Part D claims. They cover 1 drug, with $148 in total drug cost.

Dr. Beasley accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Beasley as offering telehealth. CMS counts 66 procedures of melanoma (skin cancer) excision by Dr. Beasley, more than 89% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 136 papers to Dr. Beasley, published from 2008 to 2025. 2020 was the busiest year, with 16. The most frequent topics are Melanoma, Skin Neoplasms and Sentinel Lymph Node Biopsy. Dr. Beasley has published most often in Ann Surg Oncol. Dr. Beasley's most frequent co-authors are Jonathan S. Zager, MD, Paul J. Mosca, MD and Brent Allen Hanks, MD, PhD.

Dmand AI links Dr. Beasley to 3 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Melanoma and Nevi and Melanomas. Open Payments lists research payments to Dr. Beasley that name 1 trial.

CMS Open Payments shows 27 general payments to Dr. Beasley from 6 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 90% of the total. Bristol-Myers Squibb Company paid the most, $11,325. It also lists 1 research payment totaling $443 in 2025, naming 1 clinical trial.

Dr. Beasley graduated from Duke University School Of Medicine in 2008.

Dr. Beasley is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.